Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H12O5 |
| Molecular Weight | 260.2421 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2OC=CC2=C(OC)C3=C1OC(C)=CC3=O
InChI
InChIKey=HSMPDPBYAYSOBC-UHFFFAOYSA-N
InChI=1S/C14H12O5/c1-7-6-9(15)10-11(16-2)8-4-5-18-12(8)14(17-3)13(10)19-7/h4-6H,1-3H3
| Molecular Formula | C14H12O5 |
| Molecular Weight | 260.2421 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Khellin is a crystalline extract of a crude drug, which has long been used in Egypt for the treatment of ureteral colic. It is used in the management of bronchial asthma and angina pectoris. Interest in khellin as an adjunct to ultraviolet (UV) light therapy in the treatment of vitiligo is based on the structural similarity between khellin and the psoralens. Success has been reported using oral and topical khellin in clinical studies but it is not likely that khellin will be approved for the treatment of vitiligo. Unwanted side effects of khellin include dizziness, reversible cholestatic jaundice, pseudoallergic reaction, and elevated levels of liver enzymes (transaminases and gamma-glutamyltransferase).
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24069365 |
|||
Target ID: CHEMBL3201 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24069365 |
|||
Target ID: Calcium influx Sources: https://www.ncbi.nlm.nih.gov/pubmed/2568462 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Ammivin Approved UseKhellin is used for Angina pectoris, Asthma, Vitiligo, Ultraviolet irradiation and other conditions. |
|||
| Palliative | Ammivin Approved UseKhellin is used for Angina pectoris, Asthma, Vitiligo, Ultraviolet irradiation and other conditions. |
|||
| Palliative | Ammivin Approved UseKhellin is used for Angina pectoris, Asthma, Vitiligo, Ultraviolet irradiation and other conditions. |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no [IC50 >10 uM] | ||||
| no [IC50 >10 uM] | ||||
| no [IC50 >10 uM] | ||||
| no [IC50 >10 uM] | ||||
| weak [IC50 34.6 uM] | ||||
| yes [IC50 0.04 uM] | ||||
| yes [IC50 4.02 uM] | ||||
| yes [Inhibition 10 uM] | ||||
| yes [Inhibition 10 uM] | ||||
Sources: https://pubmed.ncbi.nlm.nih.gov/24069365/ |
yes |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. | 2008-03 |
|
| Coronin-1A stabilizes F-actin by bridging adjacent actin protomers and stapling opposite strands of the actin filament. | 2008-02-22 |
|
| Competition between targeting signals in hybrid proteins provides information on their relative in vivo affinities for subcellular compartments. | 2008-02 |
|
| The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. | 2008-01 |
|
| Distinct roles for Arp2/3 regulators in actin assembly and endocytosis. | 2008-01 |
|
| Coronin-1A epigenomics governs mycobacterial persistence in tuberculosis. | 2008-01 |
|
| Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. | 2007-12 |
|
| Gene expression profiles in testis of pigs with extreme high and low levels of androstenone. | 2007-11-07 |
|
| Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain. | 2007-09-18 |
|
| An actin-based wave generator organizes cell motility. | 2007-09 |
|
| Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1. | 2007-08-29 |
|
| Lipoamide dehydrogenase mediates retention of coronin-1 on BCG vacuoles, leading to arrest in phagosome maturation. | 2007-08-15 |
|
| Synthesis of 6- and 9-alkylaminomethyl furoflavones as gastroprotective agents. | 2007-08 |
|
| Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. | 2007-07-13 |
|
| TB or not TB: calcium regulation in mycobacterial survival. | 2007-07-13 |
|
| Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. | 2007-07 |
|
| Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate. | 2007-06 |
|
| STATc is a key regulator of the transcriptional response to hyperosmotic shock. | 2007-05-21 |
|
| F-actin binding is essential for coronin 1B function in vivo. | 2007-05-15 |
|
| Coronin function is required for chemotaxis and phagocytosis in human neutrophils. | 2007-05-01 |
|
| Global gene expression analysis and regulation of the principal genes expressed in bovine placenta in relation to the transcription factor AP-2 family. | 2007-04-27 |
|
| A new steroid glycoside and furochromones from Cyperus rotundus L. | 2007-04 |
|
| Coronin 3 involvement in F-actin-dependent processes at the cell cortex. | 2007-03-10 |
|
| Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. | 2007-03-09 |
|
| The embryonic muscle transcriptome of Caenorhabditis elegans. | 2007 |
|
| Time-resolved responses to chemoattractant, characteristic of the front and tail of Dictyostelium cells. | 2006-12-11 |
|
| The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. | 2006-09-06 |
|
| Localization of CORO1A in the macrophages containing Mycobacterium leprae. | 2006-08-30 |
|
| Transcriptional regulation of artemin is related to neurite outgrowth and actin polymerization in mature DRG neurons. | 2006-08-14 |
|
| Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. | 2006-08-11 |
|
| Immunology. When F-actin becomes too much of a good thing. | 2006-08-11 |
|
| Coronins: the return of the crown. | 2006-08 |
|
| Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma. | 2006-08 |
|
| Application of 1D BIRD or X-filtered DEPT long-range C-C relay for detection of proton and carbon via four bonds and measuring long-range 13C-13C coupling constants. | 2006-04 |
|
| Microtubules regulate disassembly of epithelial apical junctions. | 2006-03-01 |
|
| Ultraviolet photoionization of the photosensitizers khellin and visnagin in aqueous solution and in micelles: one-photon ionization is a minor process. | 2006-03 |
|
| The identification of a new actin-binding region in p57. | 2006-01 |
|
| The crystal structure of murine coronin-1: a regulator of actin cytoskeletal dynamics in lymphocytes. | 2006-01 |
|
| Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. | 2006 |
|
| Nanosecond time-resolved infrared studies of visnagin and khellin triplets and radical ions. | 2005-10-20 |
|
| A novel homologue of coronin colocalizes with actin in filament-like structures in Leishmania. | 2005-10 |
|
| A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. | 2005-10 |
|
| Phosphorylation of coronin 1B by protein kinase C regulates interaction with Arp2/3 and cell motility. | 2005-09-09 |
|
| Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. | 2005-09-01 |
|
| Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. | 2005-07-29 |
|
| Dynamic properties of Legionella-containing phagosomes in Dictyostelium amoebae. | 2005-07 |
|
| Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking. | 2005-06 |
|
| Measurement of daphnoretin in plasma of freely moving rat by liquid chromatography. | 2005-05-06 |
|
| Topical khellin and natural sunlight in the outpatient treatment of recalcitrant palmoplantar pompholyx: report of an open pilot study. | 2005 |
|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991-01-01 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/npp/khella.html
Oral: 200 mg/day
Topical: as a 2% preparation
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3283251
In neutral O2-saturated aqueous solution, the photosensitized His degradation quantum yield is about 8x10(-5) for khellin. In O2-saturated aqueous solution, khellin photosensitized the oxidation of Trp with a quantum yield of 1.5x10(-4), which is quite low.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:41 GMT 2025
by
admin
on
Mon Mar 31 17:58:41 GMT 2025
|
| Record UNII |
5G117T0TJZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C45597
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
37744
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
25509
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
m6626
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB08380MIG
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
C75957
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
5G117T0TJZ
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
201-392-8
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
82-02-0
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
6147
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | RxNorm | ||
|
192
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
D007666
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
3828
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
DTXSID9045267
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
CHEMBL44746
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
KHELLIN
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
6133
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
100000083079
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY | |||
|
3313
Created by
admin on Mon Mar 31 17:58:41 GMT 2025 , Edited by admin on Mon Mar 31 17:58:41 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |